DE248984C - - Google Patents
Info
- Publication number
- DE248984C DE248984C DENDAT248984D DE248984DA DE248984C DE 248984 C DE248984 C DE 248984C DE NDAT248984 D DENDAT248984 D DE NDAT248984D DE 248984D A DE248984D A DE 248984DA DE 248984 C DE248984 C DE 248984C
- Authority
- DE
- Germany
- Prior art keywords
- protective
- therapeutic agent
- agent against
- against tuberculosis
- way
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000052616 bacterial pathogens Species 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 6
- XSTXAVWGXDQKEL-UHFFFAOYSA-N triclene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 239000003223 protective agent Substances 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 230000036760 body temperature Effects 0.000 claims description 3
- 210000004369 Blood Anatomy 0.000 claims description 2
- 210000002966 Serum Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical class C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 201000008827 tuberculosis Diseases 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N 1,2-ethanediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 206010000269 Abscess Diseases 0.000 description 1
- 241000031711 Cytophagaceae Species 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- NIPLIJLVGZCKMP-UHFFFAOYSA-M Neurine Chemical compound [OH-].C[N+](C)(C)C=C NIPLIJLVGZCKMP-UHFFFAOYSA-M 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
KAISERLICHESIMPERIAL
PATENTAMT.PATENT OFFICE.
PATENTSCHRIFTPATENT LETTERING
- JVi 248984 KLASSE 30h. GRUPPE- JVi 248984 CLASS 30 h. GROUP
Patentiert im Deutschen Reiche vom 24. Juli 1910 ab.Patented in the German Empire on July 24, 1910.
Es ist bisher nicht gelungen, durch Entfettungsmittel das in den Tubelkerbazillen enthaltene eigentümliche Wachs auf einfache Weise zu extrahieren. Deshalb war es auch nicht möglich, die wirksamen Stoffe der Tuberkelbazillen in Lösung zu bringen, wenn man nicht sehr eingreifende Verfahren anwandte, wie die Behandlung der Bakterien mit 25 prozentiger Neurinlösung bei 52 ° nach dem Verfahren von Deyke und Much. Selbst bei mehrfacher Extraktion mit den bisher sonst angewandten Mitteln, wie Alkohol-Äthermischung, Benzol, Chloroform, Petroläther u. dgl., bleiben viele Bazillen noch säurefest; im besonderen bleiben die sogenannten Muchschen Granula, die durch Gramfärbung kenntlich zu machen sind, noch färbbar.So far it has not been possible to use degreasers to extract the peculiar wax contained in the tubular bacilli in a simple manner. That's why it was not possible to bring the active substances of the tubercle bacilli into solution, if the methods used were not very invasive, such as the treatment of bacteria with 25 percent neurin solution at 52 ° using the Deyke and Much method. Even with multiple extraction with the previously used agents, such as alcohol-ether mixture, Benzene, chloroform, petroleum ether and the like, many bacilli are still acid-proof; In particular, the so-called Much's granules, which can be identified by Gram staining, can still be stained.
Es wurde nun gefunden, daß man durch Einwirkung von Trichloräthylen oder ähnliehen gechlorten Äthylenverbindungen, am zweckmäßigsten unter mehrtägigem Schütteln im Brutschrank, alle Fett- und Wachssubstanzen einschließlich der in den Muchschen Granula enthaltenen den Tuberkelbazillen entziehen kann.It has now been found that one borrowed by the action of trichlorethylene or the like Chlorinated ethylene compounds, preferably with shaking for several days in an incubator, all fat and wax substances including those contained in Much's granules from the tubercle bacilli can.
Die zurückbleibenden, von ihren Fett- und Wachssubstanzen gänzlich befreiten Tuberkelbazillen können unmittelbar als Schutz- und Heilmittel Verwendung finden. Sie werden dabei, da sie ihrer Wachs- und Fetthülle vollständig beraubt sind, ohne weiteres und ohne auch in größeren Dosen Abszesse zu verursachen, resorbiert. Sie können aber auch durch Schütteln mit Wasser oder besser mit verdünnten Alkalien oder verdünnten organisehen Basen, z. B. mit V1O bis 1A prozentigem Äthylendiamin, bei gewöhnlicher oder Körpertemperatur in Lösung gebracht werden. Die so hergestellten Lösungen oder die daraus z. B. mittels Essigsäure oder Alkohol oder anderer geeigneter Mittel ausgefällten Produkte oder die durch Eindampfen der Lösungen in konzentrierter Form gewonnenen Präparate können gleichfalls zu Immun isierungs- und Heilzwecken benutzt werden. Man kann auch Heilsera herstellen, indem man Tiere mit den entfetteten Bakterien oder ihren Extrakten vorbehandelt und deren Blut in der üblichen Weise auf Serum verarbeitet.The remaining tubercle bacilli, completely freed of their fat and wax substances, can be used immediately as protective and therapeutic agents. Since they are completely deprived of their wax and fat covering, they are absorbed easily and without causing abscesses even in large doses. But you can also by shaking with water or better with dilute alkalis or dilute organic bases, z. B. with V 1 O to 1 A percent ethylene diamine, be brought into solution at ordinary or body temperature. The solutions prepared in this way or the z. B. by means of acetic acid or alcohol or other suitable agents precipitated products or the preparations obtained by evaporating the solutions in concentrated form can also be used for immunization and healing purposes. Healing sera can also be produced by pretreating animals with the defatted bacteria or their extracts and processing their blood into serum in the usual way.
Auf Bouillonoberfläche gezüchtete Tuberkelbazillen werden durch sterile Papierfilter filtriert, gewaschen und zwischen sterilem Filtrierpapier ausgepreßt. 20 g der so erhaltenen Tuberkelbazilien werden in einer sterilen Reibschale zuerst für sich und darauf unter Zusatz geringer Mengen Trichloräthylen verrieben. Die Masse wird nunmehr mit 400 g Trichloräthylen versetzt und am besten in einem großen Glasrohr, dessen verjüngtes Ende zugeschmolzen wird, in einem Schüttelapparat bei 37 ° zwei Tage lang geschüttelt. Das Trichloräthylen wird dann abfiltriert.Tubercle bacilli grown on the surface of the broth are filtered through sterile paper filters, washed and squeezed between sterile filter paper. 20 g of the thus obtained Tubercle bacilli are first placed in a sterile mortar on their own and then added small amounts of trichlorethylene rubbed in. The mass is now with 400 g of trichlorethylene offset and preferably in a large glass tube with the tapered end fused shut is shaken in a shaker at 37 ° for two days. The trichlorethylene is then filtered off.
Um die zurückbleibende Bakteriensubstanz in Lösung zu bringen, schüttelt man den Rückstand zwei Tage lang mit 400 g V10 bis V2 prozentiger Äthylendiaminlösung oderIn order to bring the remaining bacterial substance into solution, one shakes the Residue for two days with 400 g V10 to V2 percent ethylenediamine solution or
0,2 prozentiger Kalilauge, am besten bei 37 °. Die Lösung wird schließlich durch sterile FiL· ter filtriert.0.2 percent potassium hydroxide solution, preferably at 37 °. The solution is finally passed through sterile filter filtered through.
Claims (4)
Publications (1)
Publication Number | Publication Date |
---|---|
DE248984C true DE248984C (en) |
Family
ID=507645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT248984D Active DE248984C (en) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE248984C (en) |
-
0
- DE DENDAT248984D patent/DE248984C/de active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0011243B1 (en) | Process for preparing membrane proteins from neisseria meningitidis and vaccines containing them | |
DE2902136A1 (en) | INTERFERON AND PREPARATIONS CONTAINING IT | |
DE2018588A1 (en) | Process for the isolation and purification of insulin | |
DE2512975A1 (en) | POLYPEPTIDE WITH THYMICAL EFFECTIVENESS | |
DE2457090C2 (en) | Process for the production of vaccines as well as antibronchial vaccine | |
DE2833545A1 (en) | HIGH MOLECULAR MENINGOCOCCLE GROUP C-VACCINE AND METHOD FOR THE PRODUCTION THEREOF | |
DE3152621C2 (en) | ||
DE248984C (en) | ||
DE1198489B (en) | Process for the preparation of a vaccine against panleucopenia | |
DE2652380A1 (en) | METHOD OF ISOLATION OF UTERO-EVACUATING SUBSTANCES FROM THE ZOAPATLE PLANT | |
EP0310757B1 (en) | Manufacturing process of a propolis-ethanol extract | |
DE212350C (en) | ||
DE2819297A1 (en) | PROCESS FOR SEPARATION AND CLEANING OF PRODUCTS WITH INTERFERONACTIVITY, THE PRODUCTS THEREOF AND THEIR USE AS ACTIVE INGREDIENTS | |
DE1260470B (en) | Process for the production of high polymer deoxyribonucleic acid | |
DE1966436C3 (en) | Use of an antigen-immune serum combination as a vaccine | |
DE862008C (en) | Process for introducing hydroxyl and keto groups into the 11-position of steroids | |
DE3633797C2 (en) | Process for obtaining biologically active proteins (peptides) from human and animal blood (or other body fluids) | |
CH676360A5 (en) | Purificn. of antiviral gossypol cpd. - by recrystallisation from ether with hexane | |
AT200257B (en) | ||
DE2154557B2 (en) | Process for the production of high-purity kallidinogenase (kallikrein) and a medicament containing the crystalline kallidinogenase obtained thereafter | |
CH636269A5 (en) | Process for the concentration of hepatitis B antigen and process for its purification | |
CH387226A (en) | Process for the production of a heparin-like active substance | |
DE108516C (en) | ||
DE226469C (en) | ||
DE268995C (en) |